Leizhen Zheng

Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction

Jin Li, Shukui Qin, Jianming Xu et al. · Journal of Clinical Oncology · 2016 · 976 citations

Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial

Yoon‐Koo Kang, Won Ki Kang, D.B. Shin et al. · Annals of Oncology · 2009 · 773 citations · Full text

First-line Therapy, Surgical Oncology, Gastrointestinal Oncology +7

Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis

Daoyan Wei, Xiangdong Le, Leizhen Zheng et al. · Oncogene · 2003 · 563 citations · Full text

Tumor Biology, Angiogenesis, Signaling Pathway +10

Apatinib for Chemotherapy-Refractory Advanced Metastatic Gastric Cancer: Results From a Randomized, Placebo-Controlled, Parallel-Arm, Phase II Trial

Jin Li, Shukui Qin, Jianming Xu et al. · Journal of Clinical Oncology · 2013 · 548 citations · Full text

Randomized multicenter phase III study of a modified docetaxel and cisplatin plus fluorouracil regimen compared with cisplatin and fluorouracil as first-line therapy for advanced or locally recurrent gastric cancer

Jinwan Wang, Rui‐Hua Xu, Jian Li et al. · Gastric Cancer · 2015 · 103 citations · Full text